Tremor-Dominant Movement Disorder in


Journal

Tremor and other hyperkinetic movements (New York, N.Y.)
ISSN: 2160-8288
Titre abrégé: Tremor Other Hyperkinet Mov (N Y)
Pays: England
ID NLM: 101569493

Informations de publication

Date de publication:
2024
Historique:
received: 31 05 2024
accepted: 15 09 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: epublish

Résumé

KBG syndrome is a monogenic disorder caused by heterozygous pathogenic variants in We report a 24-year-old patient harboring a pathogenic Adding to the recently described individual, our present patient highlights the relevance of movement disorders as a clinically relevant manifestation of KBG syndrome.

Sections du résumé

Background UNASSIGNED
KBG syndrome is a monogenic disorder caused by heterozygous pathogenic variants in
Case report UNASSIGNED
We report a 24-year-old patient harboring a pathogenic
Discussion UNASSIGNED
Adding to the recently described individual, our present patient highlights the relevance of movement disorders as a clinically relevant manifestation of KBG syndrome.

Identifiants

pubmed: 39346806
doi: 10.5334/tohm.926
pmc: PMC11428658
doi:

Substances chimiques

ANKRD11 protein, human 0
Repressor Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

48

Informations de copyright

Copyright: © 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Auteurs

Antonia M Stehr (AM)

Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany.

Thomas Koeglsperger (T)

Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Department of Translational Brain Research, German Centre for Neurodegenerative Diseases, Munich, Germany.

Maureen Jacob (M)

Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany.

Valerio Rhodio (V)

Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany.

Juliane Winkelmann (J)

Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
DZPG, Deutsches Zentrum für Psychische Gesundheit, Munich, Germany.

Franziska Hopfner (F)

Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Department of Translational Brain Research, German Centre for Neurodegenerative Diseases, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Michael Zech (M)

Institute of Human Genetics, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
Institute for Advanced Study, Technical University of Munich, Garching, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH